Aug 19
B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter
Drugs
November 12, 2025 - FDA Commissioner and subject matter experts from the Center for Drug Evaluation and Research discussed the agency's recent announcement regarding the removal of the "black box warning" for hormone replacement therapy.
View Recording
We know you're busy! The easiest way to keep up with us is to subscribe to our weekly e-newsletter.
You'll get the latest announcements, regulations, and upcoming events delivered to your email inbox every Monday.
Health professionals, consumers and patients can voluntarily report observed or suspected adverse events for human medical products to FDA. Voluntary reporting can help FDA identify unknown risk for approved medical products.
Learn MoreAug 19
Drugs
Aug 18
Medical Devices
Aug 17
Medical Devices
FDA is reimagining the IND Process Through Clarifying Requirements and Launching the Expedited IND Pilot.
Strengthening Our Operations and Workforce to Advance Public Trust
For 120 years the FDA's public health priorities have remained rooted in the same enduring mission.
FDA MedWatch Safety Information
You know the moment it happens.
Follow @FDAMedWatch